>

Bristol Stock Profile

<div class='circular--portrait' style='background:#754DEB;color: white;font-size:3em;padding-top: 40px;;'>BMY</div>

Performance

Odds of Distress

15
Equity ratings for Bristol Myers Squibb Company are calculated based on Macroaxis scoring framework. The performance scores are derived for the period starting November 30, 2019 and ending today February 28, 2020. Please note, there could be an existing legal relationship between Bristol Myers Squibb (BMY) and Bristol Myers Squibb (BMY.R). Click here to learn more.

Bristol Myers Profile

Next fiscal quarter end is expected on March 31, 2020. Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. Bristol-Myers Squibb Company was founded in 1887 and is headquartered in New York, New York. Bristol Myers operates under Drug ManufacturersGeneral classification in USA and is traded on BATS Exchange. more on Bristol Myers
Bristol Myers Fama & French Pharmaceutical Products
Pharmaceutical Products
Fama & French Classification
Bristol Myers Squibb SEC Filings
Bristol Myers SEC Filings
Security & Exchange Commission EDGAR ReportsView All
Legal NameBristol Myers Squibb Company
Related EntityBMY.R (Bristol Myers Squibb Co)
PresidentAnn PowellView All
Thematic Classifications
Active investing themes Bristol Myers currently participates. An investing theme is an unweighted collection of funds, stocks, ETFs or cryptocurrencies
showing 2 out of 5 themes  View All
Average Analyst Recommendation
Current trade recommendation based on an ongoing consensus estimate among financial analysis covering Bristol Myers Squibb
Piotroski F Score
Academic score to determine the current strength of Bristol Myers Squibb financial position
Macroaxis Advice
Macroaxis buy hold or sell recommendation provided in the context of your current investment horizon and risk tolerance.
Horizon: 30 days (very short)Advice
Financial Strength
Bristol Myers Squibb ability to generate sufficient cash flow to pay bills, repay debt, and make consistent year-to-year profit
Total Debt
Debt Current
Debt Non Current
Long Term Debt to Equity
Debt to Equity Ratio
Return on Investment
Return on Average Assets
Return on Average Equity
Return on Invested Capital
Return on Sales
Earnings per Basic Share
Earnings per Diluted Share
Price to Earnings Ratio
Earnings before Tax
Average Bond Rating: A+Very Firm
Profitability
Few selected profitability drivers of Bristol Myers representing accounts that assess its ability to generate profits relative to its revenue, operating costs, and shareholders' equity
Consolidated Income
Net Income
Net Income Common Stock
Operating Income
Income Tax Expense
Net Income Per Employee
Operating Margin
EBITDA Margin
Gross Margin
Profit Margin
Bristol Myers Squibb Company (BMY) is traded on BATS Exchange in USA. It is located in 430 E. 29th Street 14th Floor, New York, NY 10016, United States and employs 23,300 people. Bristol Myers is listed under Pharmaceutical Products category by Fama And French industry classification. The company currently falls under 'Large-Cap' category with total capitalization of 81.9 B. Bristol Myers Squibb runs under Healthcare sector within Drug Manufacturers?General industry. The entity has 1.64 B outstanding shares of which 63.72 M shares are currently shorted by investors with about 4.34 days to cover shorted positions. BRISTOL MYERS SQI has about 29.36 B in cash with 4.29 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 17.95.
Check Bristol Myers Probability Of Bankruptcy

Ownership Allocation (%)

Bristol Stock Price Odds Analysis

Odds Down 62.14HorizonTargetOdds Up 62.14
29.42%30 days 62.14 70.36%
Based on normal probability distribution, the odds of Bristol Myers to move above current price in 30 days from now is about 70.36 (This Bristol Myers Squibb Company probability density function shows the probability of Bristol Myers Stock to fall within a particular range of prices over 30 days) .

Bristol Stock Top Holders

Bristol Myers Squibb Company Income Statement Over Time

Direct Expenses    Earning Before Interest and Taxes EBIT    Net Income    

Bristol Stock Against Markets

Did you try this?

Run Balance Of Power Now

   

Balance Of Power

Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
All  Next Launch Module

Bristol Myers Upcoming and Recent Events

Bristol Myers Company Earnings Announcements Dates

Upcoming Quarterly Earning ReportApril 23, 2020
Next Earnings ReportJuly 23, 2020
Next Fiscal Quarter EndMarch 31, 2020
Next Fiscal Year EndFebruary 4, 2021
Last Quarter Report DateDecember 31, 2019
Last Earning Anouncement DateMarch 31, 2019

Bristol Myers Corporate Filings

Bristol Myers SEC Reporting

Unclassified Corporate Event
Financial Statements and Exhibits. Results of Operations and Financial Condition
Submission of Matters to a Vote of Security Holders
Other Events

Bristol Myers Distributions to stockholders

Continue to Trending Equities. Please also try Instant Ratings module to determine any equity ratings based on digital recommendations. macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Company logos by clearbit